Lifestyle Medicine India’s Post

MSSE FEATURED ARTICLE OF THE MONTH ⭐ In 'Relationships of Total and Domain-Specific Moderate-to-Vigorous Physical Activity with All-Cause and Disease Specific Mortality', Kikuchi and colleagues used cohort data from 81,601 community-dwelling Japanese adults to investigate the dose-response relationships of total and domain-specific MVPA (i.e. leisure-time MVPA [LT-MVPA] and work-related MVPA [WT-MVPA]) with all-cause and cause-specific mortality. Health benefits were observed at low levels of MVPA and up to 10 METs-h/day. While the fine threshold for excessive MVPA remains unclear, exceeding guidelines by double or triple did not increase mortality risk. Furthermore, the inverse association between LT-MVPA and mortality risks was more evident at lower WT-MVPA levels. Based on these findings, encouraging MVPA at leisure time is a key strategy for the working population, especially for those in sedentary jobs. Full text available here: https://brnw.ch/21wHSfu

Did you know that up to 80% of chronic diseases can be prevented or managed with a focus on lifestyle changes? Lifestyle medicine helps improve health by addressing habits like diet, exercise, and stress. It’s not just about treating illnesses—it works to reverse chronic disease trends, lower healthcare costs, and improve satisfaction for both patients and doctors. By promoting healthy habits and health equity, it supports the *Quintuple Aim*: better health, lower costs, happier patients, healthier providers, and fair access to care. I’ve written an article on DOTmed to Patient empowerment: Physician-directed and AI-driven mobile options for preventive care management. I explained this in detail. Check it out for the full read here: https://lnkd.in/gM2t6SxV

𝐁𝐫𝐢𝐠𝐡𝐭 𝐅𝐮𝐭𝐮𝐫𝐞 𝐀𝐡𝐞𝐚𝐝: 𝐄𝐱𝐩𝐥𝐨𝐫𝐢𝐧𝐠 𝐆𝐫𝐨𝐰𝐭𝐡 𝐢𝐧 𝐭𝐡𝐞 Durable #Medical Equipment 🚀 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐢𝐬 𝐏𝐃𝐅: @ https://lnkd.in/gR_T42xQ The Durable Medical #Equipment Market size was estimated to be US$ 203901.18 million in 2021 and US$ XX million in 2023 and is expected to reach US$ 339107.30 million by 2031; it is estimated to record a CAGR of 5.3% in till 2031. The market's #growth is attributed to key driving factors such as the increasing prevalence of chronic #diseases such as diabetes, cardiovascular diseases, obesity, and stroke, the increasing geriatric population, and growing incidents of road accidents. Such factors are likely to remain key Durable Medical Equipment Market trends. #𝙈𝘼𝙍𝙆𝙀𝙏_𝙊𝙑𝙀𝙍𝙑𝙄𝙀𝙒: Global durable medical equipment market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. In North America, the US is the largest market for durable medical equipment. The growth of the durable medical equipment market in North America can be attributed to the rising prevalence of chronic disorders, the increasing geriatric population, and the rise in awareness programs. As per Canadian Lung Association, 26% of Canadian adults 18 years and above are at a higher risk of sleep apnea. The condition is among the underdiagnosed respiratory disease prevalent in Canada. Additionally, Continued Positive Airway Pressure (CPAP) therapy is the most common therapy for patients with sleep apnea. Therefore, there is an increase in CPAP therapy equipment in the country. #DurableMedicalEquipment #DME #HealthcareTechnology #HomeHealthCare #MedicalDevices #HealthInnovation #PatientCare #AssistiveTechnology #MobilityAid #Telehealth

📢 Exciting News! 🎉 Thrilled to announce the publication of our latest medical article alongside the esteemed Dr. Callum Leese & Dr Blair Smith! 📄✨ Our article explores whether tackling a single lifestyle intervention or simultaneous interventions is more impactful. There is an escalating global burden of lifestyle-related diseases, which significantly contribute to chronic conditions and premature mortality. Despite the proven benefits of lifestyle interventions targeting physical inactivity, nutrition, alcohol, and smoking, these are still underutilised in primary healthcare settings. We delve into the intricate interrelations of these lifestyle factors, exploring effective strategies for integrating multiple interventions. What did we find? While simultaneous approaches for physical activity and nutrition show promise, smoking cessation might benefit from a sequential strategy. We also advocate for a holistic framework that includes sleep, mental well-being, and social connectedness, aligning with the World Health Organisation’s recommendations. The evidence on delivering these interventions together is limited, underscoring the need for further research and clinical guidance. To overcome barriers in primary care, innovative solutions such as using non-medical personnel, social prescribers, and health coaches, along with group consultations, are critical. Join us in exploring these vital strategies for promoting healthy lifestyles and improving global health outcomes! 🌍❤️ To read the full article: https://lnkd.in/evVGHREu Royal College of General Practitioners British Society of Lifestyle Medicine Red Whale parkrun

A new study by Mark Fendrick et al. explores more affordable obesity care with GLP-1, and here are our takeaways: 💸 Switching to cheaper weight maintenance programs after initial weight loss with expensive medications like GLP-1 can reduce lifetime healthcare spending. 🏋️ These cheaper programs might not be as powerful as full-dose GLP-1 treatments, but they still help keep the weight off and improve heart health. 👥 This approach makes sure that more people can benefit from initial weight loss treatments without spending too much. The study shows that cheaper weight maintenance programs save money but give fewer health benefits. This makes us ask: should we sacrifice efficacy for affordability, or try to make GLP-1 more affordable? It's also crucial to tailor these alternative programs to each person since everyone responds differently to weight loss treatments. Plus, we should focus on building lasting healthy habits for long-term health, reduced medication reliance and better obesity management. Read more: https://lnkd.in/gUjKMuVu #Obesity #ObesityManagement #Innovation #WeightLoss #AntiObesityMedications #HealthEquity #ComprehensiveCare #LongTermHealth #ObesityProgram #GLP1 #Wegovy #Ozempic #Victoza #Saxenda #Mounjaro #Diabetes #Cardiology #Heart #HeartHealth #Lifestyle #Weight #ObesityCare Oxford University Press University of Oxford #Healthcare

What are the driving factors and key market players involved in the respiratory care devices market growth? The global respiratory care devices market is projected to grow from $22.9 billion to $47.9 billion by 2033, with a CAGR of 7.6%. Key drivers include the increasing prevalence of chronic respiratory diseases, rising geriatric population, advancements in respiratory care technology, and growing demand for home healthcare solutions. The market is segmented by product, end user, and region, with North America holding significant market share due to advanced healthcare systems and high patient awareness. Key market players include Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Limited, Medtronic, Invacare Corporation, ResMed, Chart Industries, Becton, Dickinson and Company, Masimo, Koninklijke Philips N.V., and Hamilton Medical. Read more: https://lnkd.in/g_YSwKz8 Connect with us today at https://lnkd.in/e9pisJmX and embark on a journey of informed decision-making. #AMR #RespiratoryCare #MedicalDevices #Healthcare #COPD #Asthma #HomeHealthcare #MedicalTechnology #GlobalMarket #RespiratoryHealth #HealthcareInnovation

The India Respiratory Monitoring Market has been valued at USD 752.11 Million in 2023 and is expected to witness remarkable growth, with a CAGR of 7.04% from 2023 to 2029. This essential healthcare sector is transforming the way respiratory health is monitored and managed, offering new opportunities to improve patient care and outcomes. Respiratory monitoring plays a critical role in assessing and tracking breathing patterns to ensure optimal lung function. It helps detect respiratory complications early, especially in critical care units, surgical settings, and chronic disease management. The rise in respiratory disorders, advances in monitoring technologies, and increasing applications in home care settings are driving the market forward. These systems utilize sophisticated tools like spirometers, oximeters, and capnographs to deliver precise, real-time insights into respiratory health. Notably, the growing focus on CPAP devices and advancements in research & development are key market drivers. However, regions like North India, particularly Delhi, face major challenges due to severe air pollution, making the need for effective respiratory monitoring more critical than ever. Report in PDF with chart and Figures - https://lnkd.in/gAewH5Uq Report Description - https://lnkd.in/gSFypuka Key Market Players in the Indian respiratory monitoring market include: Philips India Ltd DeVilbiss Healthcare Pvt Ltd ResMed India GSK India Medtronic Pvt. Ltd. Fisher & Paykel Healthcare India Pvt Ltd Getinge Medical India Pvt Ltd MASIMO MEDICAL TECHNOLOGIES INDIA PRIVATE LIMITED As the market continues to evolve, advanced respiratory monitoring technologies will play an even more significant role in enhancing patient safety and improving overall healthcare outcomes. #Healthcare #RespiratoryMonitoring #MedicalTechnology #IndiaMarket #PatientCare #Innovation #AirPollution #MedicalDevices #HealthcareTechnology #CAGR

Unlocking Better Hypertension Management in community-based interventions: Multicomponent Interventions Lead the Way! 🌍💊 Did you know that combining "health education, training of CHWs, home visits, home BP monitoring, communication interventions telemedicine approaches and self-management of BP" can significantly improve hypertension outcomes? 📊 Studies show that multicomponent interventions yield superior results compared to single-component strategies. This comprehensive approach addresses various facets of hypertension management, leading to better patient outcomes. Hypertension affects over a billion people globally, and effective management is crucial, especially in low- and middle-income countries (LMICs). By integrating community-based strategies like health education, home BP monitoring, and self-management, we can bridge the gap in hypertension care and save lives. 🏥❤️ https://lnkd.in/gvcFE5WW #PublicHealth #HypertensionManagement #CommunityHealth #HealthcareInnovation #BPControl

Global Respiratory Care Devices Market Report, 2023-2024 and 2030: Infrastructure Improvements Key to Growth, Innovations in AI to Transform the Market Landscape - ResearchAndMarkets.com DUBLIN--(BUSINESS WIRE)--The "Global Respiratory Care Devices Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to ResearchAndMarkets.com's offering. The Respiratory Care Devices Market size is anticipated to grow to US$ 38.76 Billion by 2030 from $22.32 billion in 2023, growing with a CAGR of 8.2% during 2024-2030. The growing prevalence of respiration diseases drives the respiration care device market share, via Business Wire Health: Medical Devices News March 11, 2024, at 07:20 PM

Semaglutide: A Remarkable Evolution in Healthcare. Originally developed for diabetes management, Semaglutide has unveiled its prowess beyond its initial purpose, marking a significant milestone in medical innovation. This serendipitous discovery of weight loss in patients, without the need for stringent diets or rigorous exercise, has sparked a new era in wellness and obesity management. Furthermore, Semaglutide's journey reveals added cardiovascular benefits, contributing to a healthier heart and potentially extending its utility to anti-aging realms. At RejeuneMD Wellness & Aesthetics, we are at the forefront of integrating these breakthrough treatments into our personalized care plans. Interested in exploring how Semaglutide can enhance your health and wellness journey? Book a consultation with our experts today and be part of this transformative health revolution.